Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Durant

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Cancer Treatment Reports|April 1, 1982
Chemotherapy for advanced Hodgkin's disease: conclusions from the Southeastern Cancer Study GroupR A Gams, J R Durant, A A Bartolucci
Nature|July 6, 1989
The public understanding of scienceJ R Durant, G A Evans, G P Thomas
Radiology|November 1, 1977
The accuracy of retroperitoneal ultrasonography in Hodgkin's disease and non-Hodgkin's lymphomaD J Brascho, J R Durant, L E Green
Cancer|December 11, 1975
1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphomaJ R Durant, V Loeb, R Dorfman, et al.
Cancer|December 15, 1983
Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's diseaseA A Bartolucci, C Liu, J R Durant, et al.
The Alabama Journal of Medical Sciences|July 1, 1981
Medical pathology conference: hypoglycemia and recurrent upper gastrointestinal bleeding in a 58-year-old white manJ H Garcia, J R Durant, T M Murad, et al.
Southern Medical Journal|September 1, 1983
Thymic hyperplasia in a case of Hodgkin's diseaseJ R Grissom, J R Durant, R J Whitley, et al.
Cancer Research|March 1, 1983
Tumor proliferation and chemotherapy in immunosuppressed miceV K Ghanta, K Shrestha, J R Durant, et al.
Cancer Treatment Reviews|December 1, 1982
A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomitingS E Jones, J R Durant, F A Greco, et al.
Cancer|July 1, 1979
Unusual manifestations of non-Hodgkin's lymphomaA M Elisei, M J Norgard, J R Durant, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Cancer Treatment Reports|April 1, 1982
Chemotherapy for advanced Hodgkin's disease: conclusions from the Southeastern Cancer Study GroupR A Gams, J R Durant, A A Bartolucci
Nature|July 6, 1989
The public understanding of scienceJ R Durant, G A Evans, G P Thomas
Radiology|November 1, 1977
The accuracy of retroperitoneal ultrasonography in Hodgkin's disease and non-Hodgkin's lymphomaD J Brascho, J R Durant, L E Green
Cancer|December 11, 1975
1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphomaJ R Durant, V Loeb, R Dorfman, et al.
Cancer|December 15, 1983
Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's diseaseA A Bartolucci, C Liu, J R Durant, et al.
The Alabama Journal of Medical Sciences|July 1, 1981
Medical pathology conference: hypoglycemia and recurrent upper gastrointestinal bleeding in a 58-year-old white manJ H Garcia, J R Durant, T M Murad, et al.
Southern Medical Journal|September 1, 1983
Thymic hyperplasia in a case of Hodgkin's diseaseJ R Grissom, J R Durant, R J Whitley, et al.
Cancer Research|March 1, 1983
Tumor proliferation and chemotherapy in immunosuppressed miceV K Ghanta, K Shrestha, J R Durant, et al.
Cancer Treatment Reviews|December 1, 1982
A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomitingS E Jones, J R Durant, F A Greco, et al.
Cancer|July 1, 1979
Unusual manifestations of non-Hodgkin's lymphomaA M Elisei, M J Norgard, J R Durant, et al.
Pageof 8